The Central Cannabinoid CB1 Receptor Is Required for Diet-Induced Obesity and Rimonabant's Antiobesity Effects in Mice

CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance

(2010) Carmelo Quarta et al.   Cell Metabolism

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

(2010) Joseph Tam et al.   JOURNAL OF CLINICAL INVESTIGATION

Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions

(2009) T M Fong et al.   INTERNATIONAL JOURNAL OF OBESITY

Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats

(2008) R. Nogueiras et al.   DIABETES

CB1 receptor antagonism: biological basis for metabolic effects

(2008) Vincenzo Di Marzo   DRUG DISCOVERY TODAY

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

(2008) Douglas Osei-Hyiaman et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile

(2008) Y. Claustre et al.   NEUROSCIENCE

Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents

(2008) Andreas N. Madsen et al.   NEUROSCIENCE LETTERS

The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy Expenditure

(2008) Aaron N.A. Verty et al.   Obesity

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

(2008) J. L. McBride et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA